Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Lopucki M et al. | 2005 | placenta sample (cotyledon) | magnetic field, 50/60 Hz | 2–5 mT |
Crocetti S et al. | 2013 | intact cell/cell culture, MCF-7 cells (human breast cancer cell line) and MCF-10 cells (human non-tumorigenic breast epithelial cell line) and C2C12 cells (mouse myoblast cell line) | magnetic field, low frequency, signals/pulses, 50/60 Hz | 2–5 mT |
Ahuja YR et al. | 1999 | intact cell/cell culture, human peripheral blood leukocytes | magnetic field, 50/60 Hz | 2–10 mT |
Kim J et al. | 2012 | intact cell/cell culture, HeLa cell line (human adenocarcinoma cell line) and IMR90 (human lung fibroblasts) | magnetic field, low frequency, 50/60 Hz | 2–14 mT |
Ruiz-Gomez MJ et al. | 2010 | intact cell/cell culture, yeast (<i>Saccharomyces cerevisiae</i>)/wild type (WS8105-1C) and <i>rad52 hdf1</i> mutants (<i>rad52</i>, <i>hdf1</i>, <i>rad52 hdf1</i>; radiation sensitive 52, high affinity DNA binding factor 1) | magnetic field, 50/60 Hz | 2.45 mT |
Scarfi MR et al. | 1991 | intact cell/cell culture, human peripheral blood | magnetic field, signals/pulses, 50/60 Hz | 2.5 mT |
Scarfi MR et al. | 1994 | intact cell/cell culture, human peripheral blood lymphocytes | magnetic field, signals/pulses, 50/60 Hz | 2.5 mT |
Cossarizza A et al. | 1993 | intact cell/cell culture, human peripheral blood mononuclear cells | electric field, magnetic field, signals/pulses, 50/60 Hz | 2.5 mT |
Suri A et al. | 1996 | intact cell/cell culture, embryonic fibroblast cell line (rat) | magnetic field, 50/60 Hz, co-exposure | 3 mT |
Villarini M et al. | 2006 | intact cell/cell culture | magnetic field, 50/60 Hz, co-exposure | 3 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.